IMD-Pharma is Drug Discovery in France that focus on molecular platform business. Founded in 2016. They cover business area such as developer, chronic inflammatory disease, research, development, innovative drug, immune-relate inflammatory disease, design, immuno-modulating, anti-inflammatory molecule, unprecedented mode, action, target immune cell, their metabolism, new treatment, patient.
2016
( 8 years old in 2024 )
Molecular Platform
-
Toulouse
France
Private
developerchronic inflammatory diseaseresearchdevelopmentinnovative drugimmune-relate inflammatory diseasedesignimmuno-modulatinganti-inflammatory moleculeunprecedented modeactiontarget immune celltheir metabolismnew treatmentpatient
* We use standard office opening hours in near IMD-Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
IMD-Pharma is Drug Discovery business from France that founded in 2016 (8 years old in 2024), IMD-Pharma business is focusing on Molecular Platform.
IMD-Pharma headquarter office and corporate office address is located in Toulouse France.
IMD-Pharma was founded in France.
In 2024, IMD-Pharma is currently focus on molecular platform sector.
Above is snippet of Google Trends for "molecular platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with IMD-Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
